The Council for Responsible Nutrition is calling on the U.S. Food and Drug Administration (FDA) to act against products formulated with the Alzheimer drug galantamine and marketed as dietary supplements .
As states continue to pass bills to restrict the sale of weight loss and muscle building supplements to minors, new research shows how a little education goes a long way.
Recent statements and conversations with senior officials at the FDA have revealed “an apparent knowledge gap within the upper echelons of the Agency” regarding the regulation of dietary supplements, says Steve Mister, President and CEO of the Council for Responsible Nutrition.
On Wednesday Steve Mister, President & CEO of the Council for Responsible Nutrition (CRN), had a fireside chat with FDA Commissioner Dr. Robert Califf at CRN’s annual conference.